Cutaneous angiosarcoma

Current Problems in Cancer

Volumn 39, Issue 4, 2015, Pages 258-263

  Dossett, Lesly A ^a   Harrington, Michael ^a   Cruse, Carl Wayne ^a   Gonzalez, Ricardo J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BEVACIZUMAB; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA; SORAFENIB; TAXANE DERIVATIVE; VASCULOTROPIN INHIBITOR;

ANGIOSARCOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CUTANEOUS ANGIOSARCOMA; HUMAN; METASTASIS; HEMANGIOSARCOMA; PATHOLOGY; SKIN; SKIN NEOPLASMS;

HEMANGIOSARCOMA; HUMANS; NEOPLASM METASTASIS; SKIN; SKIN NEOPLASMS;

EID: 84941313569     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2015.07.007     Document Type: Article

References (29)

1. Maddox J.C., Evans H.L. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer 1981, 48(8):1907-1921.
2. Fury M.G., Antonescu C.R., Van Zee K.J., Brennan M.F., Maki R.G. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 2005, 11(3):241-247.
3. Abraham J.A., Hornicek F.J., Kaufman A.M., et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 2007, 14(6):1953-1967.
4. Figueiredo M.T., Marques L.A., Campos-Filho N. Soft-tissue sarcomas of the head and neck in adults and children: experience at a single institution with a review of literature. Int J Cancer 1988, 41(2):198-200.
5. Holden C.A., Spittle M.F., Jones E.W. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 1987, 59(5):1046-1057.
6. Pawlik T.M., Paulino A.F., McGinn C.J., et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 2003, 98(8):1716-1726.
7. Hamels J., Blondiau P., Mirgaux M. Cutaneous angiosarcoma arising in a mastectomy scar after therapeutic irradiation. Bull Cancer 1981, 68(4):353-356.
8. Yap J., Chuba P.J., Thomas R., et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys 2002, 52(5):1231-1237.
9. Huang J., Mackillop W.J. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 2001, 92(1):172-180.
10. Stewart F.W., Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948, 1(1):64-81.
11. Sharma A., Schwartz R.A. Stewart-Treves syndrome: pathogenesis and management. J Am Acad Dermatol 2012, 67(6):1342-1348.
12. Monroe A.T., Feigenberg S.J., Mendenhall N.P. Angiosarcoma after breast-conserving therapy. Cancer 2003, 97(8):1832-1840.
13. Roy P., Clark M.A., Thomas J.M. Stewart-Treves syndrome-treatment and outcome in six patients from a single centre. Eur J Surg Oncol 2004, 30(9):982-986.
14. Young R.J., Brown N.J., Reed M.W., Hughes D., Woll P.J. Angiosarcoma. Lancet Oncol 2010, 11(10):983-991.
15. Ohsawa M., Naka N., Tomita Y., Kawamori D., Kanno H., Aozasa K. Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Cancer 1995, 75(12):2867-2874.
16. Edge S., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. American Joint Committee on Cancer Staging Manual 2010, Springer, New York.
17. Hodgkinson D.J., Soule E.H., Woods J.E. Cutaneous angiosarcoma of the head and neck. Cancer 1979, 44(3):1106-1113.
18. Ward J.R., Feigenberg S.J., Mendenhall N.P., Marcus R.B., Mendenhall W.M. Radiation therapy for angiosarcoma. Head Neck 2003, 25(10):873-878.
19. Morrison W.H., Byers R.M., Garden A.S., Evans H.L., Ang K.K., Peters L.J. Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer 1995, 76(2):319-327.
20. Kinard J.D., Zwicker R.D., Schmidt-Ullrich R.K., Kaufman N., Pieters R. Short communication: total craniofacial photon shell technique for radiotherapy of extensive angiosarcomas of the head. Br J Radiol 1996, 69(820):351-355.
21. Ohguri T., Imada H., Nomoto S., et al. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol Biol Phys 2005, 61(5):1446-1453.
22. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997, 350(9092):1647-1654.
23. Budd G.T. Management of angiosarcoma. Curr Oncol Rep 2002, 4(6):515-519.
24. Fata F., O'Reilly E., Ilson D., et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999, 86(10):2034-2037.
25. Nagano T., Yamada Y., Ikeda T., Kanki H., Kamo T., Nishigori C. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 2007, 110(3):648-651.
26. Penel N., Bui B.N., Bay J.O., et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008, 26(32):5269-5274.
27. Agulnik M., Yarber J.L., Okuno S.H., et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 2013, 24(1):257-263.
28. Maki R.G., D'Adamo D.R., Keohan M.L., et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol 2009, 27(19):3133-3140.
29. von Mehren M., Rankin C., Goldblum J.R., et al. Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas. Cancer 2012, 118(3):770-776.